Acasti Pharma, Inc. (ACST)
NASDAQ:ACST
Holding ACST?
Track your performance easily

Acasti Pharma (ACST) Financial Statements

1,140 Followers

Acasti Pharma Financial Overview

Acasti Pharma's market cap is currently ―. The company's EPS TTM is $-1.217; its P/E ratio is -2.55; Acasti Pharma is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.34M$ -4.05M$ -2.60M$ -3.72M$ -4.31M
EBITDA$ -3.34M$ -4.05M$ -2.60M$ -3.72M$ -4.30M
Net Income Common Stockholders$ -2.62M$ -3.17M$ -2.39M$ -3.27M$ -4.02M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 19.41M$ 23.00M$ 25.11M$ 27.01M$ 21.65M
Total Assets$ 69.72M$ 73.30M$ 76.19M$ 78.21M$ 73.03M
Total Debt$ 0.00$ 0.00$ 24.00K$ 46.00K$ 80.00K
Net Debt$ -19.41M$ -23.00M$ -25.09M$ -26.96M$ -21.57M
Total Liabilities$ 10.35M$ 11.56M$ 11.51M$ 11.46M$ 9.02M
Stockholders Equity$ 59.36M$ 61.74M$ 64.68M$ 66.75M$ 64.01M
Cash Flow-
Free Cash Flow$ -3.60M$ -2.11M$ -1.89M$ -2.00M$ -6.24M
Operating Cash Flow$ -3.60M$ -2.09M$ -1.89M$ -2.11M$ -6.24M
Investing Cash Flow$ -15.00K$ 6.55M$ -6.55M$ 110.00K-
Financing Cash Flow---$ 7.36M-
Currency in USD

Acasti Pharma Earnings and Revenue History

Acasti Pharma Debt to Assets

Acasti Pharma Cash Flow

Acasti Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis